When Should We Culture Transfusion Reactions? Results from the SCARED Study

Please note: AABB reserves the right to make updates to this program.

Wednesday, February 6, 2019
2:00 – 3:00 PM (ET) 7:00 – 8:00 PM (GMT)
Master Program Number: 19EL-405 (see program format numbers below under Registration)

Educational Track: Technical/Clinical
Topic: Transfusion Medicine
Intended Audience: Hospital Blood Banks, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Managers/Supervisors, Medical Directors, Physicians, Resident/Fellow, Students (MD, MT, SBB), Technologists, Transfusion Safety Officers
Teaching Level: Intermediate

Director/Moderator: Isabella W. Martin, MD, Assistant Professor of Pathology, Medical Director of Microbiology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Speaker: Andrew Shih, MD, MSc, Clinical Assistant Professor, University of British Columbia Faculty of Medicine, Vancouver, British Columbia, Canada

Learning Objectives

After participating in this educational activity, participants should be able to:

  • List current AABB criteria for culturing residual RBCs and platelets in the setting of suspected septic transfusion reaction.
  • Discuss variation in transfusion reaction reporting and culturing rates between institutions.
  • Apply modified criteria to decision-making about when to culture residual units to improve sensitivity for positive results.

Program Description

In the setting of a suspected septic transfusion reaction, current AABB criteria can guide the decision-making process about when to culture residual units. However, these criteria as currently defined have some limitations. This program will present data from the SCARED study, a multicenter retrospective study which assessed institutional variability in residual unit and patient culturing practices and the yield of various approaches. Modified criteria are proposed which will improve the sensitivity of detecting a positive culture.

Registration

   Program #
Single Viewer: Live Register19EL-405-2035
Single Viewer: On-Demand Register19EL-405-4035
Group Viewing: Live Register19EL-405-6035
Group Viewing: On-Demand Register19EL-405-8035
Group Viewing: Live & On-Demand Register19EL-405-9935

Continuing Education Credit

AABB estimates both the live and on-demand version of this eCast each to be eligible for 1 continuing education credits/contact hours for Physicians, California Nurse, California Lab Personnel, Florida Lab Personnel and General Participation credit. The final number of credit(s) and credit types awarded for this program (live or on-demand) will be determined by the program duration. For more information on each credit type please visit our Continuing Education Credits webpage.

Speaker Biography

Dr. Shih is a Clinical Assistant Professor at the University of British Columbia Faculty of Medicine and is the Transfusion Medicine Director at Vancouver General Hospital. His academic interests include optimizing appropriateness of transfusion, optimizing damage control resuscitation, and evidence-based development of best practice guidelines.